StonvexLoading…
StonvexStonvexStonvexCore line items from RMD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.19B | $2.76B | $1.34B | $5.15B |
Operating Income | $1.44B | $938.20M | $446.54M | $1.69B |
Net Income | $1.14B | $392.59M | $348.54M | $1.40B |
EPS (Diluted) | $7.79 | $5.05 | $2.37 | $9.51 |
Total Assets | $8.78B | $8.50B | $8.31B | $8.17B |
Total Liabilities | $2.29B | $2.18B | $2.19B | $2.21B |
Cash & Equivalents | $1.66B | $1.42B | $1.38B | $1.21B |
Free Cash Flow OCF − CapEx | $1.25B | $725.56M | $414.36M | $1.66B |
Shares Outstanding | 145.04M | 145.66M | 145.94M | 146.39M |